Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin-folding cofactor B (TBCB) is a molecular chaperone involved in the biogenesis and regulation of α/β-tubulin heterodimers, acting downstream of cytosolic chaperonins to bind α-tubulin folding intermediates and guide proper tubulin assembly. TBCB forms complexes with other tubulin-folding cofactors, especially TBCE, regulating both the folding and dissociation of tubulin heterodimers. These activities are essential for microtubule organization, cell integrity, and proper cell division and growth. Disruption or altered expression of TBCB is associated with disorders of cytoskeletal dynamics, neurodevelopment, and diseases such as Kenny-Caffey syndrome[1][2][3][6][7].
Tubulin folding cofactors like TBCB participate in the biogenesis and homeostasis of tubulin dimers and can modulate microtubule stability, potentially affecting sensitivity to microtubule-modulating drugs like paclitaxel.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin-folding cofactor B (TBCB).